Peer Review History

Original SubmissionSeptember 12, 2025
Decision Letter - Kevin Vogel, Editor

PGENETICS-D-25-01020

Endosymbiont hijacking of acylcarnitines regulates insect vector fecundity by suppressing the viability of stored sperm

PLOS Genetics

Dear Dr. Weiss,

Thank you for submitting your manuscript to PLOS Genetics. After careful consideration, we feel that it has merit but does not fully meet PLOS Genetics's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript within by Dec 12 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosgenetics@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgenetics/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

* A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to formatting updates and technical items listed in the 'Journal Requirements' section below.

* A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

* An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Kevin J Vogel, Ph.D.

Guest Editor

PLOS Genetics

Kelly Dyer

Section Editor

PLOS Genetics

Aimée Dudley

Editor-in-Chief

PLOS Genetics

Anne Goriely

Editor-in-Chief

PLOS Genetics

Additional Editor Comments:

Three reviewers have provided feedback on your manuscript "Endosymbiont hijacking of acylcarnitines regulates insect vector fecundity by suppressing the viability of stored sperm." All three are in agreement that the study is well performed, described clearly, and is a significant contribution to our understanding of host-symbiont interactions. They each provide comments to clarify and improve the manuscript that should be addressed in your resubmisision.

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

1) Please ensure that the CRediT author contributions listed for every co-author are completed accurately and in full.

At this stage, the following Authors/Authors require contributions: Brian L Weiss. Please ensure that the full contributions of each author are acknowledged in the "Add/Edit/Remove Authors" section of our submission form.

The list of CRediT author contributions may be found here: https://journals.plos.org/plosgenetics/s/authorship#loc-author-contributions

2) We do not publish any copyright or trademark symbols that usually accompany proprietary names, eg ©,  ®, or TM  (e.g. next to drug or reagent names). Therefore please remove all instances of trademark/copyright symbols throughout the text, including:

- © on page: 30

- ® on page: 34

- TM on page: 34.

3) We have noticed that you have uploaded Supporting Information files, but you have not included a list of legends. Please add a full list of legends for your Supporting Information files after the references list.

4) Some material included in your submission may be copyrighted. According to PLOSu2019s copyright policy, authors who use figures or other material (e.g., graphics, clipart, maps) from another author or copyright holder must demonstrate or obtain permission to publish this material under the Creative Commons Attribution 4.0 International (CC BY 4.0) License used by PLOS journals. Please closely review the details of PLOSu2019s copyright requirements here: PLOS Licenses and Copyright. If you need to request permissions from a copyright holder, you may use PLOS's Copyright Content Permission form.

Please respond directly to this email and provide any known details concerning your material's license terms and permissions required for reuse, even if you have not yet obtained copyright permissions or are unsure of your material's copyright compatibility. Once you have responded and addressed all other outstanding technical requirements, you may resubmit your manuscript within Editorial Manager. 

Potential Copyright Issues:

i) Figure 5. Please confirm whether you drew the images / clip-art within the figure panels by hand. If you did not draw the images, please provide (a) a link to the source of the images or icons and their license / terms of use; or (b) written permission from the copyright holder to publish the images or icons under our CC BY 4.0 license. Alternatively, you may replace the images with open source alternatives. See these open source resources you may use to replace images / clip-art:

- https://commons.wikimedia.org

- https://openclipart.org/.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: The bases of most bacterial symbioses in insects are poorly understood mechanistically. This is a beautiful study exploring a possible cause of competition between spiroplasmas and the tsetse fly. The methods are clearly described and robust. The inclusion of field collected tsetse’s is a nice addition, even though they cannot be age controlled. The strength of the effects are strong and believable – sperm motility, increase in acylcarnitines despite overall reduction in lipids, reduction in spiroplasmas following RNAi of acylcarnitine synthesis gene, and patterns of gene expression that correlate with spiroplasma infection, mating, and beat frequency. The assembly of experimental approaches gives weight to the authorr's arguments. The discussion is thoughtful and incorporates relevant data across systems to provide support for speculative intepretation.

This paper was a joy to read!

Minor

Line 67 awkward. Reword.

Line 92 ‘they’ refers to trypanosomes. Confusing. Reword.

Line 175. Remind reader why lipidomics rather than a metabolomics approach

Reviewer #2: Review uploaded as an attachment.

Reviewer #3: The manuscript titled “Endosymbiont hijacking of acylcarnitines regulates insect vector fecundity by suppressing the viability of stored sperm” describes a solid study investigating how the parasitic bacteria Spiroplasmsa glossinidia (sGff) impacts the viability of tsetse fly sperm stored in the female spermathecae (sperm storing organ). The authors show that sGff impacts motility in sperm stored in the female spermathecae, but not the male testes and use RNAi and gene expression analysis to provide mechanistic evidence that the impact on spermathecae stored sperm is mediated by fly-produced acylcarnitines. Overall, this is a clean study that presents an advancement in our understanding how Spiroplasma impacts tsetse fly fecundity. I have a few minor suggestions and comments that should be considered to improve the manuscript.

Suggestions and comments

Remove speculative statements beginning with “likely,” such as “likely other tsetse species as well” (Line 153), from the Results section.

Lines 186–188: The statement “spermatozoa stored in the spermathecae of sGff+ females exhibit a motility defect” should be revised. Because sperm in male testes are inherently less active, and sperm are more active in spermathecae regardless of female infection status, it is not possible to distinguish a motility defect from an activation defect. The phrasing should remain agnostic to mechanism.

Lines 188–190: The claim that “mated Gff females that housed the bacterium presented with a relatively increased abundance of acylcarnitines in their FB” requires a reference (either to a publication or figure). The same applies to Lines 243–244: “We observed that the FB of mated sGff+ females produces more acylcarnitines than does that of their sGff– counterparts.”

What is the baseline lipidome of unmated females with and without Spiroplasma? If infection already alters lipid profiles before mating, this could affect interpretation of how sGff influences lipids in mated females.

Where multiple t-tests were performed (e.g., Line 225), please clarify whether a multiple-testing correction was applied.

The acronyms “sGff” and “Gff” are very similar and sometimes confusing. Consider using clearer or more distinct identifiers, as the similarity occasionally obscures meaning.

Line 245: The statement “This finding suggests that both hemolymph-borne and sGff localized within fly tissues may be metabolizing acylcarnitines” is not directly supported by the data. If retained, the reasoning should be explicitly stated; otherwise, it should be removed.

Several parenthetical asides are too informal for a manuscript, such as Line 266: “[amongst other things, see Materials and Methods…].” These should be rephrased or omitted.

The manuscript alternates between metabolite measurements in hemolymph and gene expression perturbations in spermathecae. Although this design is reasonable, the authors should acknowledge that these are distinct tissues and that conclusions about their interaction are inferred. Because Gff can inhabit the gut, this could also influence hemolymph lipid changes. Likewise, etomoxir treatment affects multiple tissues, so a more holistic discussion of its systemic effects—both within and outside the spermathecae—would strengthen the interpretation.

The abbreviation “GC” should be reintroduced when it reappears in the Results, as it was easy to forget by that point.

The reduced Sodalis loads observed in dsCPT1 flies merit more discussion. Although the authors state that Sodalis “has no known function related to tsetse reproduction,” absence of evidence is not evidence of absence. This finding should be interpreted rather than dismissed.

It would be helpful to mention earlier that sGff cannot synthesize lipids de novo, as this is an important aspect of its metabolism.

An additional consideration is that sGff-infected females might need to mate more frequently to maintain fecundity, potentially providing a transmission advantage to sGff. This possibility is worth noting.

Lines 526–527: The statement “we observed glandular cells associated with the outer perimeter of tsetse’s spermathecal reservoir” should clarify whether this is a novel observation or one previously reported.

Finally, please remove asterisks from lipidome panels where compounds only trend toward a difference but are not statistically significant. Because asterisks conventionally denote significance, an alternate marking would be more appropriate.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy , and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

Figure resubmission:

Reproducibility:

?>

Attachments
Attachment
Submitted filename: Weiss et al_REVIEW.pdf
Revision 1

Attachments
Attachment
Submitted filename: Weiss et al_Response to Reviewers.docx
Decision Letter - Kevin Vogel, Editor

Dear Dr Weiss,

We are pleased to inform you that your manuscript entitled "Endosymbiont hijacking of acylcarnitines regulates insect vector fecundity by suppressing the viability of stored sperm" has been editorially accepted for publication in PLOS Genetics. Congratulations!

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org.

In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Kevin J Vogel, Ph.D.

Guest Editor

PLOS Genetics

Kelly Dyer

Section Editor

PLOS Genetics

Aimée Dudley

Editor-in-Chief

PLOS Genetics

Anne Goriely

Editor-in-Chief

PLOS Genetics

www.plosgenetics.org

BlueSky: @plos.bsky.social

----------------------------------------------------

Comments from the reviewers (if applicable):

----------------------------------------------------

Data Deposition

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository . As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website .

The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: 

http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-25-01020R1

More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support.

Additionally, please be aware that our data availability policy  requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

----------------------------------------------------

Press Queries

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org .

Formally Accepted
Acceptance Letter - Kevin Vogel, Editor

PGENETICS-D-25-01020R1

Endosymbiont hijacking of acylcarnitines regulates insect vector fecundity by suppressing the viability of stored sperm

Dear Dr Weiss,

We are pleased to inform you that your manuscript entitled "Endosymbiont hijacking of acylcarnitines regulates insect vector fecundity by suppressing the viability of stored sperm" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

For Research Articles, you will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Anita Estes

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom

plosgenetics@plos.org | +44 (0) 1223-442823

plosgenetics.org | Twitter: @PLOSGenetics

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .